Paragangliomas carotídeos: hacia un tratamiento personalizado que reduzca la morbilidad

[1]  H. Neumann,et al.  Modern trends in the management of head and neck paragangliomas , 2015, European Archives of Oto-Rhino-Laryngology.

[2]  W. Mendenhall,et al.  Radiotherapy for benign head and neck paragangliomas: A 45‐year experience , 2014, Cancer.

[3]  H. Neumann,et al.  Genetics of hereditary head and neck paragangliomas , 2014, Head & neck.

[4]  W. Mendenhall,et al.  Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy , 2013, Head & neck.

[5]  J. Hamming,et al.  High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations , 2012, European Journal of Human Genetics.

[6]  J. Netterville,et al.  Natural history of cervical paragangliomas: outcomes of observation of 43 patients. , 2012, Archives of otolaryngology--head & neck surgery.

[7]  I. Mader,et al.  Head and neck paragangliomas: clinical and molecular genetic classification , 2012, Clinics.

[8]  W. Dinjens,et al.  SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. , 2011, The Journal of clinical endocrinology and metabolism.

[9]  N. Patronas,et al.  Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. , 2011, The Journal of clinical endocrinology and metabolism.

[10]  C. Cremers,et al.  SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. , 2010, The Lancet. Oncology.

[11]  A. Vénisse,et al.  The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. , 2009, The Journal of clinical endocrinology and metabolism.

[12]  E. van Marck,et al.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.

[13]  Albeir Y. Mousa,et al.  Carotid Body Tumor Surgery: Management and Outcomes in the Nation , 2009, Vascular and endovascular surgery.

[14]  C. Stratakis,et al.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes , 2009, Journal of internal medicine.

[15]  G. Rasp,et al.  Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. , 2009, Cancer research.

[16]  J. Fagan,et al.  Screening for familial paragangliomas. , 2008, Oral oncology.

[17]  A. Bonafe,et al.  Surgical Management of Carotid Body Tumors , 2008, Annals of Surgical Oncology.

[18]  J. Hamming,et al.  Resection of Carotid Body Tumors: Results of an Evolving Surgical Technique , 2008, Annals of surgery.

[19]  J. Ruben,et al.  The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. , 2008, International journal of radiation oncology, biology, physics.

[20]  A. Shaha,et al.  Tumours of familial origin in the head and neck. , 2006, Oral oncology.

[21]  J. Netterville,et al.  Carotid Body Tumor Resection: Does the Need for Vascular Reconstruction Worsen Outcome? , 2006, Annals of vascular surgery.

[22]  P. Brown,et al.  A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. , 2005, International journal of radiation oncology, biology, physics.

[23]  J. Jansen,et al.  Management of vagal paraganglioma: is operative resection really the best option? , 2005, Surgery.

[24]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[25]  D. Myssiorek,et al.  Which paragangliomas of the head and neck have a higher rate of malignancy? , 2004, Oral oncology.

[26]  R. Gilbert,et al.  Does Catecholamine Secretion from Head and Neck Paragangliomas Respond to Radiotherapy? Case Report and Literature Review. , 2003, Skull base : official journal of North American Skull Base Society ... [et al.].

[27]  D. Frank,et al.  Combined endovascular and surgical treatment of head and neck paragangliomas—A team approach , 2002, Head & neck.

[28]  R. Kline,et al.  Glomus jugulare tumor: Tumor control and complications after stereotactic radiosurgery , 2002, Head & neck.

[29]  L. Karnell,et al.  National Cancer Data Base report on malignant paragangliomas of the head and neck , 2002, Cancer.

[30]  J. Plukker,et al.  Outcome of surgical treatment for carotid body paraganglioma , 2001, The British journal of surgery.

[31]  A. V. D. van der Mey,et al.  Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal , 2000, Cancer.

[32]  G. Cavallaro,et al.  Baroreflex failure syndrome after bilateral excision of carotid body tumors: an underestimated problem. , 2000, Journal of vascular surgery.

[33]  J. Shohet,et al.  Malignant Glomus Tumors , 1999, The Laryngoscope.

[34]  A. Hill,et al.  Should patients be screened for asymptomatic carotid artery stenosis? , 1998, Canadian journal of surgery. Journal canadien de chirurgie.

[35]  Vinod K. Anand,et al.  Management of the internal carotid artery during carotid body tumor surgery , 1995, The Laryngoscope.

[36]  C. Cornelisse,et al.  Does Intervention Improve the Natural Course of Glomus Tumors? , 1992, The Annals of otology, rhinology, and laryngology.

[37]  P. Maaswinkel-Mooy,et al.  GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY , 1989, The Lancet.

[38]  I. Lau,et al.  High‐altitude paragangliomas diagnostic and therapeutic considerations , 1986, Cancer.

[39]  James S. Brown.  Glomus jugulare tumors revisited: A ten‐year statistical follow‐up of 231 cases , 1985, The Laryngoscope.

[40]  S. Sheps,et al.  Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. , 1971, American journal of surgery.

[41]  F. S. L. Sánchez.  Indicaciones quirúrgicas en paragangliomas carotídeos. Cambio del paradigma y propuesta de algoritmos , 2017 .

[42]  V. Grégoire,et al.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy , 2013, European Archives of Oto-Rhino-Laryngology.

[43]  H. Bartelink,et al.  Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  C. Cremers,et al.  Familiar non-chromaffinic paragangliomas (glomus tumors). Clinical and genetic aspects (abridged). , 1981, Acta oto-laryngologica.